Term ends Feb 2, 2027 · Medium confidence
20-year base term ends Feb 2, 2027
Why Medium: The disclaimer's references carry disclaimers of their own not yet read (US 7,732,595), so the cap could be lower.
Held by Gilead Sciences, Inc.
Filed Apr 22, 2010 as application 12/765,623 · Granted Jan 31, 2012
Base term, 20 years from filing
Today
2007
2027
Clock starts
Feb 2, 2007
Feb 2, 2007
Term ends
Feb 2, 2027
Feb 2, 2027
Granted
Jan 31, 2012
Jan 31, 2012
base term
fee events
Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
No effect
Terminal disclaimer
Resolved from the filed document, referencing US 7,671,192, US 7,732,595, to Feb 2, 2027. The term already ends on or before that date, so the cap shortened nothing.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
8
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. All three maintenance fees are recorded paid; no more fees are due. Confidence: Medium. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Feb 2, 2007, when application 11/701,699, the earliest non-provisional in its chain, was filed (this one was filed Apr 22, 2010) | Feb 2, 2027 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 7,671,192, US 7,732,595) | resolves to Feb 2, 2027, no earlier than this term, so no change | Medium confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 3 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Feb 2, 2027 | Medium confidence |
This family
| US 7,732,595 | In force no later than Jul 2027 | no later than Jul 2027 |
| US 7,671,192 | In force Apr 2027 | Apr 2027 |
| US 7,956,179 | In force Feb 2027 | Feb 2027 |
| US 8,106,183 | this patent Feb 2027 | Feb 2027 |
| US 8,268,988 | In force Feb 2027 | Feb 2027 |
| US 8,524,883 | In force Feb 2027 | Feb 2027 |
| US 9,085,601 | Surrendered on reissue Mar 2019 | Mar 2019 |
| US RE47,301 | In force Feb 2027 | Feb 2027 |
The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Apr 22, 2011 Reel 26171, frame 71 | Zablocki, Jeff; Elzein, Elfatih | CV Therapeutics, Inc. | Assignment of Assignor's Interest |
| Apr 22, 2011 Reel 26171, frame 82 | Apex Merger Sub, Inc.; CV Therapeutics, Inc. | Gilead Palo Alto, Inc. | Merger |
| Jun 10, 2011 Reel 26424, frame 925 | Gilead Palo Alto, Inc. | Gilead Sciences, Inc. | Assignment of Assignor's Interest |
| Jan 29, 2013 Reel 29716, frame 839 | Lemons, Travis; Seemayer, Robert | Gilead Sciences, Inc. | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Feb 2027
Term ends Feb 2, 2027. No further fees fall due before then
Terminal disclaimer
A terminal disclaimer resolved from the filed document, referencing US 7,671,192, US 7,732,595, ends no earlier than this term, so it caps nothing.
Citations
9
later US patents cite this one
That is above the median of utility patents granted in 2012 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.